Sleep Testing Services Market Witnesses Launch of Home Sleep Testing Devices Due to Emergence of Covid-19
Sleep testing has become a common method of diagnosing obstructive sleep apnea. It is an important diagnostic tool because it helps in the identification of obstructive sleep apnea syndrome. It is performed by placing monitors on the patient's body at specific times during the night and recording the data. This data is essential in determining the causes of the condition and the need for treatment.
Sleep apnea is a
potentially serious sleep disorder in which breathing repeatedly stops and
starts. The sleep testing services market is driven by high prevalence of sleep
apnea. According to the study, ‘Estimation of the global prevalence and burden
of obstructive sleep apnea: a literature-based analysis’, published in July
2019, 936 million adults aged 30–69 years have mild to severe obstructive sleep
apnea and 425 million adults aged 30–69 years have moderate to severe
obstructive sleep apnea globally.
An EEG
(electroencephalograph) is used to monitor brain waves during your sleep. A
frequency is sent by the electrodes to the earphones that allow the technician
to listen to the brain waves. The sleep stage is determined by the brain waves.
If you exhibit falling into one of the sleep stages, the electrodes will give a
low or high frequency signal, which is decoded by the computer and compared
with patterns in your sleep videotapes.
Players in the sleep testing services market may focus on offering clinical-grade diagnostic
technologies at a low cost. In February 2021, Vivos Therapeutics, Inc., a
medical technology company, launched VivoScoreTM, powered by SleepImage for
home sleep apnea testing in children and adults.
At-home sleep testing
services is a new trend in the sleep testing services market, due to the
emergence of Covid-19. Globally, as of 5:04pm CET, 11 March 2021, there have
been 117,799,584 confirmed cases of COVID-19, including 2,615,018 deaths, as reported
to the World Health Organization. As of 10 March 2021, a total of 300,002,228
vaccine doses have been administered.
As the pandemic
continues to spread, players in the sleep testing services market are focused
on development and launch of home sleep testing devices. In October 2020,
WatchPAT 300 Home Sleep Apnea Testing device, a flagship product of Itamar
Medical, a medical device and digital health company, was granted PMDA approval
for use in the Japanese market, effective September 14, 2020.
Comments
Post a Comment